BIT 2.94% 3.5¢ biotron limited

Ann: Presentation of BIT225-009 HIV-1 Phase 2 Data, page-253

  1. 11,142 Posts.
    lightbulb Created with Sketch. 478
    Whilst you think I'm downramping, I'm simply clarifying an earlier post.

    BIT said in an announcement back in September "Analysis of the trial data is ongoing. The Company aims to present detailed data at scientific conferences and to potential commercial partners in late 2018/early 2019".

    I'm just highlighting that it's not new data, it's just interpreting the data further.  A phase 3 trial still needs to occur.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.5¢
Change
0.001(2.94%)
Mkt cap ! $30.67M
Open High Low Value Volume
3.3¢ 3.5¢ 3.3¢ $11.94K 346.4K

Buyers (Bids)

No. Vol. Price($)
1 155932 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 65500 1
View Market Depth
Last trade - 15.59pm 22/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.